it use should be confine to qualified oncologist or other health professional specialise in the administration of cytotoxic agent .
the AUC and Cmax of cinacalcet increase approximately linearly over the dose range of 30 to 180 mg once daily .
EU / 1 / 01 / 185 / 072 1 pack EU / 1 / 01 / 185 / 073 4 pack
capsule shell contain gelatin , titanium dioxide E171 ; ink contain iron oxide E172 .
ALIMTA be use in combination with cisplatin in patient who have not be treat before , and on it own in patient who have receive another type of chemotherapy in the past .
instruction ON USE
Valdoxan tablet may be take with or without food .
14 000 000
you may need to read it again .
3 .
6.5 Nature and content of container
once control of asthma be attain treatment should be review and consideration give a to whether patient should be step down to an inhaled corticosteroid alone .
blood and lymphatic system disorder
Uncommon : common : common :
treatment of symptomatic anaemia associate with chronic kidney disease ( CKD ) .
adult Based on the patient ’ s current dose of metformin , Zomarist may be initiate at either the 50 mg / 850 mg or 50 mg / 1000 mg tablet strength twice daily , one tablet in the morning and the other in the evening .
how do Aloxi work ?
follow intravenous administration , an approximate 25 % difference between du
16 .
co-administration of REYATAZ with ritonavir in dos greater than 100 mg once daily have not be clinically evaluate .
expiry DATE
90 film-coated tablet multipack comprise 3 pack , each contain 30 tablet .
this document be a summary of the European Public Assessment Report ( EPAR ) .
it be recommend , however , to administer Myfenax at least one hour before or three hour after sevelamer intake to minimise the impact on the absorption of MPA .
pharmacological PROPERTIES
since cinacalcet lower serum calcium , patient should be monitor carefully for the occurrence of hypocalcaemia ( see section 4.2 ) .
a report for other gyrase inhibitor , ciprofloxacin cause damage to the large weight-bearing joint in immature animal .
this improvement enable the body to fight infection that may have be present with no obvious symptom .
do not use Pegasys after the expiry date which be state on the label .
take your next dose the next day at the usual time .
other
EXP :
the safety data base from clinical trial comprise 2 ’ 737 CKD patient , include 1 ’ 789 patient treat with MIRCERA and 948 with another ESA .
congenital agammaglobulinemia or hypogammaglobulinemia , common variable immunodeficiency , severe combine immunodeficiency , Wiskott Aldrich syndrome .
MARKETING Authorisation Holder Boehringer Ingelheim International GmbH D-55216 Ingelheim be Rhein Germany
{ MM-YYYY }
there be no adequate and well-controlled trial of aripiprazole in pregnant woman .
Pharma Tel . : + 36 1 457 65 00
600 , single
injection site inflammation , injection site reaction , fatigue , rigor , fever § , influenza-like symptom § , malaise , irritability
14 November 2007
the absolute bioavailability of subcutaneously administer Puregon be approximately 77 % .
treatment regimen
one informal meeting of the CVMP take place in Dublin in September 1996 .
13 .
MARKETING Authorisation Holder and Manufacturer
generally Puregon dissolve immediately .
the absolute bioavailability ( AUC ) of deferasirox from
under no circumstance must Ceftriaxone solution be mix with solution contain calcium .
olanzapine administer with lithium or valproate result in increased level ( ≥ 10 % ) of tremor , dry mouth , increase appetite , and weight gain .
read the package leaflet before use .
- you have frequent episode of hypoglycaemia ,
in that study the incidence of fatal thromboembolic event be higher in patient receive epoetin alfa than in those receive placebo ( see section 5.1 ) .
- if you have psoriasis , it may get worse during treatment with Viraferon .
person with a history of severe hypoglycemia should have glucagon available .
for severe infection parenteral form of cefuroxime be recommend .
PHARMACEUTICAL FORM
what Zyrtec IS AND WHAT IT IS USED FOR
animal data show embryo-foetal toxicity at very high exposure level .
you should contact your doctor for advice on drive if :
light green , oval , film-coated tablet mark “ Amgen ” on one side and “ 30 ” on the other .
2 .
adverse reaction of Remeron
81 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
MARKETING authorisation holder Norbrook Laboratories Limited Station work Newry Co .
5 .
ARCOXIA ARCOXIA 30 mg , 60 mg , 90 mg , 120 mg Arcoxia 30 , 60 , 90 , 120 mg Arcoxia Arcoxia Arcoxia 30 , 60 , 90 ja 120 mg tabletti , kalvopäällysteinen Turox 30 , 60 , 90 ja 120 mg tabletti , kalvopäällysteinen
a hypo mean your blood sugar level be too low .
there be no experience regard the administration of Irbesartan Hydrochlorothiazide BMS in patient with a recent kidney transplantation .
30
14 .
close monitoring for hepatic abnormality be recommend
Firazyr be not for self-administration .
ViraferonPeg alone be not study in HCV / HIV co-infected patient .
pharmacological PROPERTIES
the product be supply a a pack of 1 vial of powder with 1 pre-filled syringe of solvent for reconstitution and 15 disposable syrinx for administration graduate in FSH unit .
& lt ; 25 x 109 / l
Glomerulonephritis , blood creatinine increase
15 .
when indinavir be administer a monotherapy resistant virus rapidly emerge ( see section 5.1 ) .
reproductive system disorder
common : muscle cramp
1 .
& # 91 ; to be complete nationally & # 93 ;
8 ANNEX II
withdrawal PERIOD
dose reduction or split the daily dose have not be show to provide benefit .
the safety of continued SUTENT treatment in patient with moderate to severe proteinuria have not be systematically evaluate .
when use with VIRACEPT , the lowest possible dose of atorvastatin should be administer .
23 July 2008
subsequent infusion rate should be calculate base on the actual FVIII level and recalculate clearance for each day post surgery base on the equation : clearance = infusion rate / actual FVIII level .
12 / 18
caution must also be exercise if indinavir be use concurrently with atorvastatin .
15 %
insulin release :
in clinical trial in patient with drug-induced ( dopamine agonist ) psychosis associate with Parkinson ’ s disease , worsen of Parkinsonian symptomatology and hallucination be report very commonly and more frequently than with placebo .
Italia Grifols Italia S. p . a .
this product contain lactose monohydrate .
only use each syringe for one injection .
and 24 cleanse swab .
no mutation associate with high degree resistance specifically to stavudine have be reveal in vivo .
kg Tel : + 49 ( 0 ) 89 360448701 produkt . info @ gsk . com
0 % ) ; Lymphoedema ( G3 / 4 :
for patient with prior failure on therapy with nonpegylated interferon or pegylated interferon and negative at Week 12 , the sustained response rate be 59 % and 50 % , respectively .
medicinal product subject to medical prescription .
the insulin should be mix by turn OptiSet slowly up and down at least 10 time .
pen barrel Me
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
solution for injection in pre-filled syringe .
1 mg / chewable tablet
each vial of 0.6 ml contains 12 mg methylnaltrexone bromide .
thiazide have be show to increase the urinary excretion of magnesium , which may result in hypomagnaesemia .
Orgalutran be a clear and colourless aqueous solution for injection .
CoAprovel should not be give to child and adolescent ( under 18 year ) .
cardiac status must be assess before start of therapy and monitor clinically during therapy ; if any deterioration occur , therapy must be stop ( see section 4.2 ) .
Austria
5 .
Loratadin
common :
dosage adjustment in specific patient population Patients with liver impairment Dose reduction may be necessary in patient with severe liver impairment in order to maintain the blood trough level within the recommended target range .
127
if you can not keep your appointment , be sure to contact your doctor right away to discuss another date when you can come in for your injection .
España Pfizer S.A .
psoriatic arthritis
ed 2 .
plasma HCV-RNA be measure with a research-based QUANTITATIVE polymerase chain reaction assay by a central laboratory * Intent to treat population include 7 patient for whom at least 12 week of prior therapy could not be confirm .
the concomitant administration of clopidogrel with oral anticoagulant be not recommend since it may increase the intensity of bleeding ( see section 4.5 ) .
you should check with your doctor or pharmacist if you be not sure .
sanofi Pasteur MSD Ltd , Tel : + 44.1.628.785.291
note : some air may remain in the pen , but this be not important a you have remove the air from the injection needle and the dose will be accurate .
3 .
these elevation in transaminase be generally asymptomatic , non-progressive in nature and not associate with cholestasis or jaundice .
61.0 ( 72 / 118 ) 49.5 , 72.6
26 Magnesium stearate maize starch Meglumine Microcrystalline cellulose Povidone ( K25 ) Red ferric oxide ( E172 ) Sodium hydroxide Sodium starch glycollate ( type A ) sorbitol ( E420 ) .
neonatal and juvenile animal study in rat and dog demonstrate that there be no adverse effect see in any of the standard developmental or maturation endpoint at dos up to 1800 mg / kg / day correspond to 30 time the maximum recommend human dose .
136 ( 40 ) 5 ( 1 )
pericardial effusion echocardiogram abnormal
Tel : + 43 ( 0 ) 1 26 044 msd-medizin @ merck . com
renal impairment In patient with moderate to severe renal dysfunction ( serum creatinine level & gt ; 2.5 mg / dl ) , accumulation of the intravenous vehicle , SBECD , occur .
1A2 , 2D6 , 2C9 , 2C19 , 3A4 ) .
there be , however , only a modest increase in biologic activity a measure by a bioassay .
at each step , the increase or reduction in dose should be of 25 IU / kg 3 time per week .
treat animal therefore should not be bath until the solution have dry .
Viraferon be give in combination with ribavirin . t uc
Tel : + 386 1 5204201 MSD _ Slovenia @ merck . com
irbesartan Hydrochlorothiazide BMS
Jet Generici S. R. L .
Overleaf :
EU / 1 / 00 / 160 / 037-048
Tel : + 420 - 2 20382111
how to take Onsenal 4 .
10 pen of 3 ml .
Furthermore , the pharmacodynamic activity of clopidogrel be not significantly influence by the co- administration of phenobarbital , cimetidine , or oestrogen .
in case of administration by a non health care professional appropriate training be need .
- in whom glycaemic control be markedly improve ,
- against calicivirus infection to reduce clinical sign and excretion ,
woman of childbearing potential should use a reliable contraceptive to avoid pregnancy whilst be treat with DepoCyte .
Infanrix hexa be not intend for use in child over 36 month of age .
0.65 MM
or Dompé Biotec S. p . a .
RA Study IIa * *
55 % ( 46 % ) 28 % ( 26 % ) 26 % ( 25 % ) 5 % ( 4 % ) 40 % ( 43 % )
it can also develop if the body produce too much glucagon .
see ENCLOSED package leaflet .
6 mg
179 PACKAGE LEAFLET :
6 .
it be advise to adhere to the recommend starting dos indicate below .
further INFORMATION
Noxafil treatment should be start by a doctor who have experience in the management of fungal infection or of treat patient at high risk of Invasive fungal infection .
Escherichia coli , Bacillus spp . , Enterococcus spp . , and Klebsiella spp . be reduce , a be the anaerobe Bacteroides vulgatus , Bifidobacterium spp . , Eubacterium spp . , and Peptostreptococcus spp ..
once a patient meet all laboratory and clinical criterion for a complete response , MabCampath should be discontinue and the patient monitor .
in in vitro study , the protein binding of amprenavir be approximately 90 % .
2
break off the top of the ampoule of solvent .
lot
Norway
STAMARIL
5.1 Pharmacodynamic property
COVERSYL
package size
Lamictal
over 8,000 patient ( hip fracture – 1,711 , hip replacement – 5,829 , major knee surgery – 1,367 ) be study in controlled Phase II and III clinical study .
hyperglycaemia
Rasagiline pharmacokinetics be linear with dose over the range of 0.5-2 mg .
Hold the bottle and the syringe firmly in one hand and with the other hand pull back the plunger slightly beyond the mark for the dose require .
how do posaconazole SP work ?
name AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
14 .
subcutaneous use
centralised procedure for Veterinary Products
0.3 0.4 0.5 0.4 0.5 0.5 0.5
what be Zarzio ?
all
1 bottle
Ammonaps be a long-term treatment and need to be take until the patient have a successful liver transplant .
keep out of the reach and sight of child
Annex
do not use Ciprofloxacin Bayer after the expiry date , which be state on the carton after & quot ; EXP & quot ; :
in patient 3 year of age or older , TMZ be only to be use in recurrent or progressive malignant glioma .
child weigh le than 14 kg will need to use separate oral solution contain lamivudine and zidovudine .
ri In this leaflet :
read all of this leaflet carefully before you start take this medicine .
24 , 47 % ; p & lt ; 0.001 ) , mainly relate to a reduction in occluded infarct-related artery .
6.6 Special precaution for disposal and other handling
Special PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS , IF APPROPRIATE
8 .
Č eská republika Boehringer Ingelheim spol . s r. o .
LABELLING AND PACKAGE LEAFLET
name OF THE MEDICINAL PRODUCT AND ROUTE ( S ) OF ADMINISTRATION
general Disorders and Administration site CONDITIONS
8 .
6.1 List of excipients
it be essential for patient with pre-existing or gestational diabetes to maintain good metabolic control throughout pregnancy .
tablet
Betaferon 250
ENGERIX B can be give concomitantly with BCG , DTP , dt and / or polio vaccine , if this fit conveniently in an immunisation scheme recommend by the country Health authority .
thereafter blood level of tacrolimus should be monitor carefully during co-administration , and upon discontinuation of posaconazole , and the dose of tacrolimus should be adjust a necessary .
when methoxy polyethylene glycol-epoetin beta be administer subcutaneously to male and female rat prior to and during mating , reproductive performance , fertility , and sperm assessment parameter be not affect .
Optaflu should not be use in people who may be hypersensitive to the active substance or any of the other ingredient .
GONAL-f should be give a a course of daily injection simultaneously with lutropin alfa .
expiry DATE
Cat
lot
preparation collect necessary item before you begin :
Special WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT na
6.5 Nature and composition of immediate packaging
if you or your child be often sick , you should inform your doctor .
• Actraphane • insulin human , rDNA • Part A
2 / 20 Use of the veterinary medicinal product should be base on identification of infect organism and susceptibility testing and take into account official and local Antimicrobial policy .
film-coated tablet
28.5 ± 8.6
5 .
AUTHORISATION Holder
2 .
the liver and kidney be find to be the major target organ .
in clinical trial in patient with drug-induced ( dopamine agonist ) psychosis associate with Parkinson ’ s disease , worsen of Parkinsonian symptomatology and HA llucinations be report very commonly and more frequently than with placebo .
9 .
development or exacerbation of diabetes occasionally associate with ketoacidosis or coma , include some fatal case ( see section 4.4 ) Hypothermia
8 .
Dynastat be preservative free .
it main measure of effectiveness be the proportion of patient who have have a ‘ major cytogenetic response ’ ( the proportion of the patient ’ s white blood cell that contain the Philadelphia chromosome have fall to below 35 % ) .
12 .
29 % 17 % 29 %
CIALIS have be show to increase the effect of these medicine .
Tel : + 40 ( 0 ) 21 317 31 36
0.088 mg 0.088 mg 0.18 mg 0.18 mg 0.7 mg 0.7 mg 1.1 mg 1.1 mg 0.35 mg 0.35 mg
the next injection should be do at the same time the next day .
exposure to dasatinib may be expect to increase if liver function be impaired ( see section 4.4 ) .
Austria
Special population Patients with renal impairment No dose adjustment be necessary for patient with mild or moderate renal impairment where serum creatinine be equal or below 200 μ mol / l ( 2.3 mg / dl ) or where creatinine clearance ( measure or estimate ) be equal or greater than 30 ml / min .
tenofovir disoproxil fumarate have not be clinically evaluate in patient receive medicinal product which be secrete by the same renal pathway , include the transport proteins human organic anion transporter ( hOAT ) 1 and 3 or MRP 4 ( e. g. cidofovir , a know nephrotoxic medicinal product ) .
Dermatological reaction
2-18 D-61118 Bad Vilbel Germany
in the study of patient with a single demyelinating event , Extavia be show to reduce the risk of develop clinically define MS :
elderly mild renal ( 75 year ) impairment CrCL :
take special care with Trudexa : no
Portugal Merck Sharp & amp ; Dohme , Lda Tel : + 351 21 446 57 00 informacao _ doente @ merck . com
ciprofloxacin should be co-administered with another appropriate antibacterial agent unless ciprofloxacin-resistant Neisseria gonorrhoeae can be exclude .
vial
8 .
keep out of the reach and sight of child .
patient have a median platelet count of 14 x 109 / l at study entry .
check and mix the insulin
219 ( n = 363 )
България MERCK d. o. o .
BATCH NUMBER
after subcutaneous administration at the same dose repeat every 48 hour for 4 dos , a moderate accumulation occur ( about 2.5 x for AUC ) .
data with AVANDAMET be also consistent with this combined adverse reaction profile .
Pharma Tel . : + 36 1 457 65 00
- difficulty breathing .
the frequency of ADRs report with MabThera alone or in combination with chemotherapy be summarise in the table below .
QUALITATIVE AND QUANTITATIVE COMPOSITION
start on Day 8 with 10-15 minute outdoors .
lp
general CLASSIFICATION FOR SUPPLY
10 .
always use Enbrel exactly a the doctor have tell you .
MARKETING AUTHORISATION NUMBER ( S )
rash
Advocate for small cat
GONAL-f 1050 IU / 1.75 ml ( 77 microgram / 1.75 ml ) preparation must not be reconstitute with any other GONAL-f container .
Infertile men with hormonal deficiency .
however , an increase to a maximum 20 mg dose should be carefully consider depend on the individual tolerability ( see section 4.4 and 4.8 ) .
administration of activated charcoal may also be use to aid in removal of unabsorbed active substance .
further information
pharmacological PROPERTIES
- The active substance be recombinant interferon alfa-2b , 10 million IU / ml .
mirtazapine
what be Ebixa use for
28 % 16 % 26 % 145 -0.48 1 %
• ER shorten time to tumour progression in patient with advanced head and neck cancer receive ng radiation therapy when administer to target a haemoglobin of greater than 14 g / dl ( 8.7 mmol / l ) , ESAs be not indicate for use in this patient population . lo
glycoprotein IIb / IIIa inhibitor : clopidogrel should be use with caution in patient who may be at risk of increased bleeding from trauma , surgery or other pathological condition that receive concomitant glycoprotein IIb / IIIa inhibitor ( see section 4.4 ) .
Tel : + 353 ( 0 ) 1 403 56 00
neutrophil and white cell count reduction at the end of week 4 correlate with the dose of Peg Intron .
Equilis StrepE - solvent
potential interaction affect olanzapine Since olanzapine be metabolise by CYP1A2 , substances that can specifically induce or inhibit this isoenzyme may affect the pharmacokinetics of olanzapine .
treatment with Aerius also significantly reduce interference with sleep and daytime function , a measure by a four-point scale use to assess these variable .
139 4.6 Pregnancy and lactation
au accumulation be observe with either route of administration .
15 Nicotinic acid be not carcinogenic in mouse when administer for the duration of their life .
this mean that it help to prevent blood clot from form .
6 .
read the package leaflet before use .
4.9 Overdose
50 1 .
Bayer HealthCare Manufacturing S. r. l .
for cisplatin and 5-fluorouracil dose adjustment , see the corresponding summary of product characteristic .
CONDITIONS OF THE MARKETING AUTHORISATION
fondaparinux be excrete to 64 – 77 % by the kidney a unchanged compound .
seek medical advice immediately : • if sign of allergy spread to other part of the body , or • if you suddenly feel unwell and you start sweat ; start be sick ( vomit ) ; have difficulty in breathe ; have a rapid heart beat ; feel dizzy ; feel like fainting .
alcohol may intensify and prolong the hypoglycaemic effect of insulin .
7 .
make sure you finish / your child finish the complete vaccination course of three injection .
do not put the pre-filled pen next to the freezer compartment or a freezer pack .
EU / 1 / 04 / 285 / 027
the powder be contain in a 2 ml vial , Type I flint glass , with a butyl rubber stopper in an aluminium flip-off seal with a polypropylene bonnet .
1 .
- If you be allergic ( hypersensitive ) to somatropin or to any of the other ingredient of
the ( E ) -isomer account for 95 % of the AUC of entacapone .
common : orthostatic hypotension , hypotension
4.4 Special warning and precaution for use
do not remove the adapter from the plastic housing .
unless continue losartan therapy be consider essential , patient plan pregnancy should be change to alternative anti-hypertensive treatment which have an establish safety profile for use in pregnancy .
5 .
control clinical trial have not show significant benefit attributable to the administration of epoetins when haemoglobin concentration be increase beyond the level necessary to control symptom of anaemia and to avoid blood transfusion .
always take Zerit exactly a your doctor have tell you .
- If you be ill or have a major injury then your blood sugar level may increase ( hyperglycaemia ) .
Suomi / Finland Novartis Finland Oy Puh / Tel : + 358 9 61 33 22 11
12 .
15 .
clinical PARTICULARS
part A Part B extension & amp ; Abridged application
5.1 Pharmacodynamic property
MIRCERA 150 microgram / 0.3 ml solution for injection in pre-filled syringe
sildenafil , tadalafil Interaction not study .
thiazide may decrease urinary calcium excretion and cause an intermittent and slight elevation of serum calcium in the absence of known disorder of calcium metabolism .
the available pre-clinical data on growth suggest an impairment of bone development / growth in young rodent expose to fluoxetine .
list below be the most common medicine which may affect your insulin treatment .
vision problem .
if ALT level be increase to & gt ; 3x upper limit of normal during rosiglitazone therapy , liver enzyme level should be reassess a soon a possible .
the treatment be divide into two stage :
bromobutyl stopper with steel blue colour seal .
for single use only .
a causal relationship to somatropin therapy be unlikely .
your blood sugar may get too high ( this be call hyperglycaemia ) .
Actrapid be accompany by a package leaflet with detailed instruction for use to be follow .
BATCH NUMBER
what Omnitrope contains
Deutschland Servier Deutschland GmbH Tel : + 49 ( 0 ) 89 57095 01
QUALITATIVE AND QUANTITATIVE COMPOSITION
the effect of Kaletra ( in combination with other antiretroviral agent ) on biological marker ( plasma HIV RNA level and CD4 count ) have be investigate in a controlled study of Kaletra of 48 week duration , and in additional study of Kaletra of 360 week duration .
concomitant use of Puregon and clomifene citrate may enhance the follicular response .
patient with chronic hepatitis B or C and treat with combination antiretroviral therapy be at an increase risk for severe and potentially fatal hepatic adverse reaction .
4 .
183 9 .
in the first study , VIRACEPT in combination with stavudine ( another antiviral medicine ) be compare with stavudine alone in 308 patient who have not take stavudine or a protease inhibitor in the past .
oral
4 .
more severe episode with coma , seizure , or neurologic impairment may be treat with intramuscular / subcutaneous glucagon or concentrate intravenous glucose .
DATE of first authorisation :
disseminate intravascular coagulation ( DIC ) , often in association with sepsis or multiorgan failure , have be report .
België / Belgique / Belgien Bayer S. A . / N. V. , Tél / Tel : + 32- ( 0 ) 2-535 63 11 България Байер България ЕООД Тел . + 359 02 81 401 01 Č eská republika Bayer s. r. o .
België / Belgique / Belgien Rue de Stalle / Stallestraat 73 B-1180 Bruxelles / Brussel / Brüssel Tél / Tel : + 32- ( 0 ) 2 370 92 11
- unaccustomed , increase or prolonged physical activity ,
chronic renal failure patient
a ritonavir be recommend to be take with food and didanosine should be take on an empty stomach , dose should be separate by 2.5 h .
the very first injection of Puregon should be give under medical supervision .
to be supply only on veterinary prescription .
if allergic or anaphylactic reaction occur , the injection / infusion should be stop immediately and patient should contact their physician .
not all pack may be market .
7 , 10 , 20 , 30 , 50 , 100
because the active substance in Aclasta be the same a the active substance in Zometa , some of the data present for Zometa be take into account when assess Aclasta .
30-60
nervous system disorder
animal study do not indicate direct or indirect harmful effect with respect to pregnancy , embryonic / foetal development , parturition or postnatal development ( see section 5.3 ) .
store in a refrigerator .
• Grade 3
absolute oral bioavailability relative to intravenous administration have not be determine .
EU / 2 / 97 / 004 / 030
if you stop take Doxastad 4 mg prolong release tablet and associate name Keep take your tablet until your doctor tell you to stop .
side effect report uncommonly ( Seen in le than 1 in 100 but more than 1 in 1000 patient ) • Severe allergic reaction with low blood pressure ( shock ) • Injection site urticaria ( itchy rash )
tell your relative , friend and close colleague the following :
if you need more information about your medical condition or your treatment , read the Package Leaflet ( also part of the EPAR ) or contact your doctor or pharmacist .
irbesartan exhibit linear and dose proportional pharmacokinetics over the dose range of 10 to 600 mg .
each pack of Herceptin contain one vial .
use of injection site should be rotate so that the same site be not use more than approximately once a month .
DISPOSAL : read package leaflet .
efficacy have be demonstrate with Zonegran in 4 double-blind , placebo-controlled study of period of up to 24 week with either once or twice daily dosing .
Antineoplastic agent , monoclonal antibody , ATC code :
medicinal product subject to restrict medical prescription ( See Annex I :
therefore , it be important to consider this diagnosis in patient who present with diarrhoea during or subsequent to the administration of Doribax ( see section 4.8 ) .
1 single use pre-filled syringe 4 single use pre-filled syrinx
if a patient experience a reaction suggestive of hypersensitivity , subsequent test for imiglucerase antibody be advise .
if you think any of these apply to you , do not take the tablet .
the primary activity of insulin , include insulin glargine , be Regulation of glucose metabolism .
other
efficacy against otitis medium
very rare case of allergic reaction to GONAL-f have occur cause redness of the skin , rash , swell , hive and difficulty in breathing .
if you have them , you may have have a serious allergic reaction to i dic
in the table below all adverse reaction , which occur at an incidence greater than placebo and in more than one patient , be list by class and frequency ( very common ( & gt ; 1 / 10 ) , common ( & gt ; 1 / 100 , & lt ; 1 / 10 ) , uncommon ( & gt ; 1 / 1000 , & lt ; 1 / 100 ) and rare ( & lt ; 1 / 1000 ) ) .
Atripla be not recommend for patient with moderate or severe renal impairment .
indication
AVANDAMET 4 mg / 1000 mg tablet rosiglitazone / metformin HCl
1.1 The Management Board
Τηλ : + 30 210 629 4600 España Daiichi Sankyo España , S.A .
PRT Rua da Quinta do Pinheiro , 5 P-2795 Carnaxide - Lisboa
the amount or timing of insulin , food or exercise may need to be adjust .
in a second study , sixty-six ferret be divide into 6 cohort of 11 ferret and be immunize on day 0 and 21 with 3.75 µg or 7.5 µg of the Indonesia vaccine or be sham vaccinate .
in use pen In use pre-filled pen may be store for a maximum of 4 week not above 25 ° C away from direct heat or direct light and must not be store in the refrigerator . do not use it after this time period .
other SPECIAL WARNING ( S ) , IF NECESSARY
for detail please refer to http : / / www . emea . europa . eu / htms / human / EPAR / eparintro .
myalgia Hypersensitivity reaction ( such a anaphylaxis , angioedema , dyspnoea , pruritus , rash , and urticaria )
n
solution for injection in a pre-filled syringe
injection site should be rotate within the same region .
the usual total daily dose be 1 mg / kg body weight divide in morning and evening administration .
Lyophilisate for suspension for injection
each tablet contain 400 mg of raltegravir ( a potassium ) .
this be true for all HCV Genotypes , particularly genotype 1 , in which the relapse rate be reduce by 30 % compare with interferon alfa-2b monotherapy .
Hyponatremia Hyponatremia have be report rarely , predominantly in the elderly , when administer YENTREVE .
what should you do if you experience hypoglycaemia
target Reduced
therefore , in patient with known hypertension and / or other cardiac disease , blood pressure monitoring be recommend , especially during the first month of treatment .
concomitant food intake do not significantly influence the bioavailability of irbesartan .
recent myocardial infarction The valsartan In acute myocardial infarction trial ( VALIANT ) be a randomised , control , multinational , double-blind study in 14,703 patient with acute myocardial infarction and sign , symptom or radiological evidence of congestive heart failure and / or evidence of left ventricular systolic dysfunction ( manifest a an ejection fraction ≤ 40 % by radionuclide ventriculography or ≤ 35 % by echocardiography or ventricular contrast angiography ) .
approximately 75 % of the administer dose be eliminate via faeces and the remainder via urine .
do not freeze .
if intolerance persists after dose adjustment or if granulocyte decrease to & lt ; 250 / mm3 or ALT / AST rise to & gt ; 10 x upper limit of normal , discontinue interferon alfa -2b therapy .
• When nitric oxide and oxygen combine , they form a chemical call nitrogen dioxide .
in this subgroup , there be a 92 % ( 89 / 97 ) sustain virological response rate .
irbesartan be not remove by haemodialysis .
method AND ROUTE ( S ) OF ADMINISTRATION
o
th ( 7.5 mmol / l ) .
recombinant coagulation factor VIII be produce from genetically engineer baby hamster kidney cell contain the human factor VIII gene .
name OF THE MEDICINAL PRODUCT
common ( ≥ 1 / 100 to & lt ; 1 / 10 )
after 12 month , the proportion of patient respond to the treatment be 61 % for Visudyne-treated patient compare with 46 % for placebo-treated patient .
it be strongly recommend that every time you receive a dose of CEPROTIN the name and batch number of the product be record in order to maintain a record of the batch use .
if the push-button can not rise freely , some of your insulin will be push out of the needle • The scale on the cap show 0 , 2 , 4 , 6 , 8 , 10 , 12 , 14 , 16 and 18 unit .
- If you weigh between 86 and 105 kg , take 3 capsule in the morning and 3 in the evening ( total
conjugate to tetanus toxoid a a carrier t
name OF THE MEDICINAL PRODUCT
the movement must always be repeat until the liquid appear uniformly white and cloudy .
if a patient develop sign and symptom indicative of NMS , or present with unexplained high fever without additional clinical manifestation of NMS , all antipsychotic medicinal product , include ABILIFY , must be discontinue .
6.6 Special precaution for disposal and other handling
CONDITIONS OF THE MARKETING AUTHORISATION
the safety of the co-administration of fosamprenavir with low dose ritonavir be establish in two pivotal Phase III trial :
analysis lopinavir / ritonavirb ( 400 mg / 100 mg twice daily )
1 .
it be recommend that you take OSSEOR at bedtime .
for patient who experience a sustained increase in blood pressure while receive duloxetine either dose reduction or gradual discontinuation should be consider ( see section 4.8 ) .
4.1 Therapeutic indication
the frequency of the following adverse event , which have be report during clinical study and / or post-marketing use , be categorize base on an assessment of their incidence rate in large , long-term , placebo-controlled , clinical trial include HPS and 4S with 20,536 and 4,444 patient , respectively ( see section 5.1 ) .
contains lactose monohydrate , see leaflet for further information .
the use of auricular preparation may be associate with hear impairment , usually temporary , and primarily in geriatric dog .
4.4 Special warning and special precaution for use
if they occur , the dose of levodopa should be decrease .
4 In two placebo-controlled six week trial in patient with chronic idiopathic urticaria , Neoclarityn be effective in relieve pruritus and decrease the size and number of hive by the end of the first dosing interval .
mild reddening of the ear have be observe .
5.2 Pharmacokinetic property
combination with a sulphonylurea In controlled clinical trial with the combination of vildagliptin 50 mg + a sulphonylurea , the overall incidence of withdrawal due to adverse reaction be 0.6 % in the vildagliptin 50 mg + sulphonylurea v 0 % in the placebo + sulphonylurea treatment group .
adalimumab be a recombinant human monoclonal antibody express in Chinese Hamster Ovary cell .
 26 Children and adolescent :
6 .
body Weight ( kg )
16 .
bradycardia QT c prolongation ( see section 4.4 )
NUMBER of
store in a refrigerator ( 2ºC - 8ºC ) .
4 .
4.8 Undesirable effect
store in a refrigerator .
the policy of hold public ‘ info-days ’ with the principal partner of the EMEA will be refine and dialogue with pharmaceutical company will be continue , both with meeting at the EMEA or meeting at the London satellite office of the European trade association .
medicinal product not subject to medical prescription .
before use OptiSet , the Instructions for Use include in the Package Leaflet must be read carefully .
ZOSTAVAX induce a significantly higher VZV-specific immune response measure by gpELISA at 4 week postvaccination , compare with placebo ( 2.1-fold difference ( 95 % CI :
European Medicines Agency
further INFORMATION
what Zyrtec IS AND WHAT IT IS USED FOR
where appropriate you will receive oral dos of iron , ideally start before the Binocrit treatment begin .
insulin treatment of the nursing mother present no risk to the baby .
• Tell your doctor if you have have kidney disease , or if test have show problem with your kidney .
the combination should be avoid ( see section 4.5 ) .
4.5 Interaction with other medicinal product and other form of interaction
a le than proportional increase in oral absorption at dos beyond 600 mg ( twice the maximal recommend dose ) be observe ; the mechanism for this be unknown .
Tel : + 351 21 000 8600
5 .
a a result no dose adjustment for Riprazo or these co-administered medicinal product be necessary .
none
